首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備 DDS

市場調查報告書

商品編碼

1983173

鼻腔給藥系統市場：依劑型、容器類型、系統類型、治療應用、通路和地區分類。

Nasal Drug Delivery Systems Market, By Dosage Form, By Container Type, By System Type, By Therapeutics Application, By Distribution Channel, By Geography

出版日期: 2026年02月12日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，鼻腔給藥系統市場規模估計為983億美元，預計2033年將達到1,346.7億美元。預計2026年至2033年，該市場將以8.2%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	983億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2025-2032 年）複合年成長率	8.20%	預計金額（2033 年）	1346.7億美元

由於其諸多優勢，例如避免肝臟首過代謝以及最重要的－患者用藥便利性，鼻腔正成為最有前景的給藥途徑之一。鼻腔給藥系統可用於疼痛管理、急性偏頭痛治療、過敏性和非過敏性鼻炎以及由鼻竇炎、普通感冒或鼻炎引起的鼻塞。當需要快速起效或其它給藥途徑無效時，通常會以鼻內給藥。鼻腔給藥系統可實現全身給藥和無針免疫接種。液體鼻內製劑可透過吸入器、滴鼻劑、噴霧泵、霧化器或霧化器給藥。

市場動態

預計在預測期內，與鼻腔給藥系統相關的研發活動的增加將推動全球鼻腔給藥系統市場的成長。例如，2022年4月5日，總部位於英國的合約研發生產機構（CDMO）Upperton Pharma Solutions推出了「UpperNose」鼻腔給藥開發平台，該平台旨在幫助中小型創新企業利用必要的知識和能力，成功開發鼻腔給藥製劑。

此外，監管機構產品核可的增加預計將推動預測期內鼻腔給藥市場的成長。例如，2021年10月18日，處於商業化階段的生物製藥公司Oyster Point Pharma宣布，美國食品藥物管理局（FDA）已核准TYRVAYA（Varenicline溶液）鼻噴霧0.03毫克用於治療乾眼症的症狀和體徵。 TYRVAYA鼻噴霧是目前唯一核准用於治療乾眼症的鼻噴霧。 TYRVAYA鼻噴霧被認為能夠與膽鹼能受體結合並活化三叉神經副交感神經通路，從而增加基礎淚液分泌，達到治療乾眼症的目的。

本報告的主要特點

本報告對全球鼻腔給藥系統市場進行了詳細分析，包括預測期（2025-2032 年）的市場規模和複合年成長率，以 2024 年為基準年。
此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文根據以下參數，介紹了全球鼻腔給藥系統市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球鼻腔給藥系統市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球鼻腔給藥系統市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

熱圖分析
市佔率分析（3x3矩陣）
公司簡介
- Merck & Co., Inc.
- GlaxoSmithKline plc
- AstraZeneca plc
- Johnson &Johnson
- Pfizer Inc.
- Baxter International, Inc.
- Valeant Pharmaceuticals International, Inc.
- Becton
- Dickinson and Company
- Novartis AG

第11章分析師建議

機會
分析師意見
Coherent Opportunity Map (COM)

第12章參考文獻與分析方法

參考
分析方法

簡介目錄

Product Code: CMI1944

Nasal Drug Delivery Systems Market is estimated to be valued at USD 98.3 Bn in 2026 and is expected to reach USD 134.67 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 98.3 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.20%	2033 Value Projection:	USD 134.67 Bn

Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience. The nasal drug delivery systems used in the treatment of pain, acute migraine treatment, allergic and non-allergic rhinitis, and nasal congestion brought on by sinusitis, the common cold, or rhinitis. Nasal medication delivery is typically employed when a beginning of action is desired or when other routes of administration prove unsuccessful. Systemic drug administration and needle-free immunization is possible with the help of nasal drug delivery systems. It is possible to use inhalers, droppers, spray pumps, nebulizers, or atomizers to give liquid nasal solutions.

Market Dynamics

Increasing research and development activities for nasal drug delivery systems is expected to drive growth of the global nasal drug delivery system market over the forecast period. For instance, on April 5, 2022, Upperton Pharma Solutions, a U.K. based contract development and manufacturing organization (CDMO) had launched a nasal delivery development platform, UpperNose, for small and mid-sized innovators to access the knowledge and capabilities required for the successful development of nasal dose formulations.

Furthermore, increasing product approvals by regulatory authorities is expected to drive growth of the nasal drug delivery market over the forecast period. For instance, on October 18, 2021, Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company had announced that the U.S. Food and Drug Administration (FDA) had approved TYRVAYA (varenicline solution) Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease. TYRVAYA Nasal Spray is the first and only nasal spray approved for the treatment of dry eye disease. TYRVAYA Nasal Spray is believed to bind to cholinergic receptors to activate the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment for dry eye disease.

Key features of the study

This report provides an in-depth analysis of the global nasal drug delivery systems market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nasal drug delivery systems market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nasal drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery systems market

Market Segmentation

By Dosage Form
- Nasal Spray
- Nasal Drops
- Nasal Gels
- Nasal Powders
- Others
By Container Type
- Non-pressurized Containers
- Pressurized Containers
By System Type
- Multi Dose
- Bi Dose
- Unit Dose
By Therapeutics Application
- Allergic and Non-allergic Rhinitis
- Nasal Congestion
- Vaccination
- Others
By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Merck & Co., Inc.
- GlaxoSmithKline plc
- AstraZeneca plc
- Johnson & Johnson
- Pfizer Inc.
- Baxter International, Inc.
- Valeant Pharmaceuticals International, Inc.
- Becton
- Dickinson and Company
- Novartis AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Dosage Form
- Market Snippet, By Container Type
- Market Snippet, By System Type
- Market Snippet, By Therapeutics Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Nasal Drug Delivery Systems Market, By Dosage Form, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Nasal Spray
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Nasal Drops
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Nasal Gels
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Nasal Powders
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Nasal Drug Delivery Systems Market, By Container Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Non-pressurized Containers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pressurized Containers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Nasal Drug Delivery Systems Market, By System Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Multi Dose
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bi Dose
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Unit Dose
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Nasal Drug Delivery Systems Market, By Therapeutic Application, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Allergic and Non-allergic Rhinitis
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Nasal Congestion
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Vaccination
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

8. Global Nasal Drug Delivery Systems Market, By Distribution Channel, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

9. Global Nasal Drug Delivery Systems Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Merck & Co., Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GlaxoSmithKline plc
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- AstraZeneca plc
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson & Johnson
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Pfizer Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Baxter International, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Valeant Pharmaceuticals International, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Becton
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Dickinson and Company
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Novartis AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates